Regarding the expression of GSK-3 in brain tumors, Miyashita and collaborators reported higher expression levels and activity of GSK-3β in GBM compared with normal brain tissues (Miyashita et al. 2009). This evidence concerns the gene GSK3B and glioblastoma.